Jilin Aodong Pharmaceutical Group Co., Ltd. Stock price
Equities
000623
CNE000000719
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.36 CNY | +0.21% | -4.07% | -5.15% |
Sales 2023 * | 3.45B 477M | Sales 2024 * | 4.12B 570M | Capitalization | 17.26B 2.39B |
---|---|---|---|---|---|
Net income 2023 * | 2.06B 285M | Net income 2024 * | 2.33B 322M | EV / Sales 2023 * | 5 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 4.19 x |
P/E ratio 2023 * |
8.11
x | P/E ratio 2024 * |
7.16
x | Employees | 5,399 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 71.21% |
1 day | +0.21% | ||
1 week | -4.07% | ||
Current month | -5.40% | ||
1 month | -4.01% | ||
3 months | -5.34% | ||
6 months | -16.80% | ||
Current year | -5.15% |
Managers | Title | Age | Since |
---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Kai Yang
DFI | Director of Finance/CFO | 47 | 04-04-30 |
Da Long Zhao
DFI | Director of Finance/CFO | 50 | 99-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiu Lin Li
CHM | Chairman | 71 | 93-01-31 |
Shu Qin Guo
CEO | Chief Executive Officer | 61 | 97-12-31 |
Yong Feng Chen
CHM | Chairman | 57 | 00-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 14.36 | +0.21% | 9,532,032 |
24-03-27 | 14.33 | -0.90% | 8,954,162 |
24-03-26 | 14.46 | +0.49% | 8,287,771 |
24-03-25 | 14.39 | -1.44% | 12,854,440 |
24-03-22 | 14.6 | -2.47% | 18,393,130 |
End-of-day quote Shenzhen S.E., March 27, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.15% | 2.39B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |